You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 11, June 13, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic

Heart Failure Management Programs Reduce Readmissions and Prolong Survival

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their recent systematic review and meta-analysis of the overall impact of multidisciplinary management programs on the risk of readmission and all-cause mortality in patients with chronic heart failure (CHF), Gwadry-Sridhar et al1 concluded that this type of intervention had a positive impact on morbidity but minimal impact on mortality. Our own meta-analysis of these same programs2 concluded that CHF management programs not only reduce the risk of readmission (risk ratio [RR], 0.84; 95% confidence interval [CI], 0.75-0.93) but also reduce the risk of all-cause mortality (RR, 0.83; 95% CI, 0.70-0.99). There are 2 important explanations why these analyses reached different conclusions.

First, for reasons that are not clear, Gwadry-Sridhar et al1 chose to limit their analysis to 7 trials involving 1113 patients with CHF, published prior to the year 2000 (plus their own unpublished study, involving an additional 126 patients). Notably, 2 large randomized trials published in Lancet and . . . [Full Text of this Article]


AUTHOR INFORMATION
Simon Stewart, PhD, FESC, FAHA; Finlay A. McAlister, MD, MSc, FRCPC; John J. V. McMurray, MD, FESC, FACC


RELATED ARTICLES

Heart Failure Management Programs Reduce Readmissions and Prolong Survival—Reply
Femida H. Gwadry-Sridhar, Virginia Flintoft, Douglas S. Lee, and Gordon H. Guyatt
Arch Intern Med. 2005;165(11):1311-1312.
EXTRACT | FULL TEXT  

A Systematic Review and Meta-analysis of Studies Comparing Readmission Rates and Mortality Rates in Patients With Heart Failure
Femida H. Gwadry-Sridhar, Virginia Flintoft, Douglas S. Lee, Hui Lee, and Gordon H. Guyatt
Arch Intern Med. 2004;164(21):2315-2320.
ABSTRACT | FULL TEXT  

Interventions to Prevent Readmission for Congestive Heart Failure
Barbara Riegel, Mary Naylor, Simon Stewart, John J. V. McMurray, and Michael W. Rich
JAMA. 2004;291(23):2816.
EXTRACT | FULL TEXT  

Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study
Wendy A. Gattis, Vic Hasselblad, David J. Whellan, and Christopher M. O'Connor
Arch Intern Med. 1999;159(16):1939-1945.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.